Biotage AB (publ) (BITGF) Short Interest Ratio & Short Volume $11.50 0.00 (0.00%) As of 04/2/2025 Add Compare Share Share Short Interest Stock AnalysisChartShort InterestBuy This Stock Biotage AB (publ) Short Interest DataBiotage AB (publ) (BITGF) has a short interest of 117,900 shares. This marks a 76.23% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 267 shares to cover all short positions.Current Short Interest117,900 sharesPrevious Short Interest66,900 sharesChange Vs. Previous Month+76.23%Dollar Volume Sold Short$1.36 millionShort Interest Ratio0.0 Days to CoverLast Record DateMarch 15, 2025Today's Trading Volume0 sharesAverage Trading Volume267 sharesToday's Volume Vs. Average0% Short Selling Biotage AB (publ)? Sign up to receive the latest short interest report for Biotage AB (publ) and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBITGF Short Interest Over TimeBITGF Days to Cover Over TimeBITGF Percentage of Float Shorted Over Time Remove Ads Biotage AB (publ) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2025117,900 shares $1.36 million +76.2%N/A0 $11.50 2/28/202566,900 shares $769,350.00 +66.0%N/A334.5 $11.50 2/15/202540,300 shares $523,900.00 -24.8%N/A0 $13.00 1/31/202553,600 shares $696,800.00 -11.6%N/A0 $13.00 1/15/202560,600 shares $787,800.00 +9.6%N/A606 $13.00 12/31/202455,300 shares $820,099.00 -0.2%N/A553 $14.83 12/15/202455,400 shares $819,920.00 +18.4%N/A0 $14.80 11/30/202446,800 shares $692,640.00 +33.0%N/A0 $14.80 11/15/202435,200 shares $520,960.00 +27.1%N/A352 $14.80 10/31/202427,700 shares $443,200.00 +27.1%N/A277 $16.00 Get the Latest News and Ratings for BITGF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biotage AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 10/15/202421,800 shares $403,736.00 +3.3%N/A218 $18.52 9/30/202421,100 shares $390,772.00 +22.7%N/A0 $18.52 9/15/202417,200 shares $318,544.00 -3.4%N/A172 $18.52 8/31/202417,800 shares $328,499.00 +1.1%N/A2.2 $18.46 8/15/202417,600 shares $324,808.00 -17.4%N/A88 $18.46 7/31/202421,300 shares $393,091.50 -8.6%N/A106.5 $18.46 7/15/202423,300 shares $365,577.00 No ChangeN/A116.5 $15.69 6/30/202423,300 shares $365,577.00 No ChangeN/A116.5 $15.69 6/15/202423,300 shares $340,879.00 No ChangeN/A232.8 $14.63 5/31/202423,300 shares $340,879.00 -6.8%N/A0 $14.63 5/15/202425,000 shares $365,750.00 -12.6%N/A0 $14.63 4/30/202428,600 shares $418,418.00 +18.7%N/A95.3 $14.63 4/15/202424,100 shares $406,567.00 -2.8%N/A0 $16.87 3/31/202424,800 shares $418,376.00 +0.4%N/A248 $16.87 3/15/202424,700 shares $407,550.00 -14.8%N/A247 $16.50 2/29/202429,000 shares $478,500.00 -27.9%N/A290 $16.50 2/15/202440,200 shares $482,400.00 +0.5%N/A0 $12.00 1/15/202440,600 shares $487,200.00 +4.4%N/A58 $12.00 12/31/202338,900 shares $466,800.00 -12.8%N/A0 $12.00 12/15/202344,600 shares $535,200.00 +13.2%N/A0 $12.00 11/30/202339,400 shares $472,800.00 -66.5%N/A394 $12.00 11/15/2023117,700 shares $1.27 million +5.7%N/A1177 $10.75 10/31/2023111,400 shares $1.09 million +14.9%N/A79.6 $9.80 10/15/202397,000 shares $873,000.00 +0.1%N/A970 $9.00 9/30/202396,900 shares $935,085.00 No ChangeN/A969 $9.65 9/15/202396,900 shares $969,000.00 +11.4%N/A34.6 $10.00 8/31/202387,000 shares $1.04 million +27.9%N/A0 $12.00 8/15/202368,000 shares $816,000.00 +143.7%N/A24.3 $12.00 7/31/202327,900 shares $334,800.00 +469.4%N/A46.5 $12.00 7/15/20234,900 shares $58,800.00 +104.2%N/A4.9 $12.00Trump’s Secret Weapon (Ad)Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.Get Your FREE Presidential Transition Guide Today 6/30/20232,400 shares $28,800.00 No ChangeN/A3 $12.00 6/15/20232,400 shares $28,800.00 -4.0%N/A0 $12.00 5/31/20232,500 shares $30,000.00 No ChangeN/A0 $12.00 5/15/20232,500 shares $30,000.00 -40.5%N/A0 $12.00 4/30/20234,200 shares $50,400.00 +68.0%N/A42 $12.00 4/15/20232,500 shares $30,000.00 -40.5%N/A0 $12.00 3/31/20234,200 shares $50,400.00 +68.0%N/A42 $12.00 3/15/20232,500 shares $35,000.00 -40.5%N/A6.3 $14.00 2/28/20234,200 shares $65,310.00 +68.0%N/A42 $15.55 2/15/20232,500 shares $42,500.00 No ChangeN/A0 $17.00 1/31/20232,500 shares $42,500.00 -39.0%N/A0 $17.00 1/15/20234,100 shares $69,700.00 +46.4%N/A0 $17.00 12/30/20222,800 shares $47,600.00 No ChangeN/A14 $17.00 12/15/20222,800 shares $41,300.00 No ChangeN/A0 $14.75 11/30/20222,800 shares $41,300.00 -31.7%N/A0 $14.75 11/15/20224,100 shares $60,475.00 -77.2%N/A0 $14.75 10/31/202218,000 shares $265,500.00 +22.5%N/A0 $14.75 10/15/202214,700 shares $216,825.00 -12.0%N/A0 $14.75 9/30/202216,700 shares $246,325.00 +51.8%N/A167 $14.75 9/15/202211,000 shares $231,000.00 -19.1%N/A110 $21.00 8/31/202213,600 shares $285,600.00 +3.0%N/A136 $21.00 8/15/202213,200 shares $277,200.00 -13.2%N/A132 $21.00 7/31/202215,200 shares $319,200.00 +2.7%N/A152 $21.00 7/15/202214,800 shares $251,600.00 No ChangeN/A0 $17.00 6/30/202214,800 shares $251,600.00 No ChangeN/A148 $17.00 6/15/202214,800 shares $281,940.00 No ChangeN/A29.6 $19.05 5/31/202214,800 shares $244,200.00 -5.1%N/A0 $16.50 5/15/202215,600 shares $257,400.00 +13.0%N/A0 $16.50 4/30/202213,800 shares $227,700.00 +146.4%N/A0 $16.50 4/15/20225,600 shares $92,400.00 +124.0%N/A56 $16.50 3/31/20222,500 shares $41,250.00 -16.7%N/A0 $16.50 3/15/20223,000 shares $49,500.00 No ChangeN/A30 $16.50 2/28/20223,000 shares $75,000.00 No ChangeN/A30 $25.00 2/15/20223,000 shares $75,000.00 No ChangeN/A0 $25.00 1/31/20223,000 shares $75,000.00 No ChangeN/A30 $25.00 1/15/20223,000 shares $75,000.00 +3.5%N/A30 $25.00 12/31/20212,900 shares $85,361.50 No ChangeN/A29 $29.44 12/15/20212,900 shares $85,361.50 -72.1%N/A29 $29.44 11/30/202110,400 shares $306,124.00 No ChangeN/A104 $29.44 11/15/202110,400 shares $258,960.00 +11.8%N/A104 $24.90 10/29/20219,300 shares $231,570.00 +190.6%N/A0 $24.90 10/15/20213,200 shares $79,680.00 +28.0%N/A16 $24.90 9/30/20212,500 shares $55,000.00 No ChangeN/A0 $22.00 9/15/20212,500 shares $55,000.00 No ChangeN/A0 $22.00 8/31/20212,500 shares $55,000.00 +4.2%N/A0 $22.00 8/13/20212,400 shares $52,800.00 No ChangeN/A24 $22.00 7/30/20212,400 shares $52,800.00 No ChangeN/A24 $22.00 7/15/20212,400 shares $52,800.00 No ChangeN/A0 $22.00 6/30/20212,400 shares $52,800.00 -7.7%N/A24 $22.00 6/15/20212,600 shares $57,200.00 -10.3%N/A26 $22.00Trump’s Secret Weapon (Ad)Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.Get Your FREE Presidential Transition Guide Today 5/28/20212,900 shares $63,800.00 +11.5%N/A29 $22.00 5/14/20212,600 shares $57,200.00 No ChangeN/A0 $22.00 4/30/20212,600 shares $57,200.00 +8.3%N/A26 $22.00 4/15/20212,400 shares $41,565.60 No ChangeN/A0 $17.32 3/31/20212,400 shares $41,565.60 No ChangeN/A0 $17.32 3/15/20212,400 shares $41,565.60 -68.0%N/A12 $17.32 2/26/20217,500 shares $120,000.00 No ChangeN/A0 $16.00 2/12/20217,500 shares $120,000.00 +212.5%N/A0 $16.00 1/29/20212,400 shares $38,400.00 No ChangeN/A0 $16.00 1/15/20212,400 shares $38,400.00 No ChangeN/A0 $16.00 12/31/20202,400 shares $0.00 No ChangeN/A24 $0.00 BITGF Short Interest - Frequently Asked Questions What is Biotage AB (publ)'s current short interest? Short interest is the volume of Biotage AB (publ) shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 117,900 shares of BITGF short. Learn More on Biotage AB (publ)'s current short interest. Is Biotage AB (publ)'s short interest increasing or decreasing? Biotage AB (publ) saw a increase in short interest in March. As of March 15th, there was short interest totaling 117,900 shares, an increase of 76.2% from the previous total of 66,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Biotage AB (publ)'s short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Biotage AB (publ): Straumann Holding AG (1.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Biotage AB (publ) stock? Short selling BITGF is an investing strategy that aims to generate trading profit from Biotage AB (publ) as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biotage AB (publ)? A short squeeze for Biotage AB (publ) occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BITGF, which in turn drives the price of the stock up even further. How often is Biotage AB (publ)'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BITGF, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies AddLife AB (publ) Short Interest Data Ansell Short Interest Data Ansell Short Interest Data Carl Zeiss Meditec Short Interest Data Coloplast A/S Short Interest Data ConvaTec Group Short Interest Data EssilorLuxottica Société anonyme Short Interest Data Fielmann Group Short Interest Data Fielmann Group Short Interest Data Fisher & Paykel Healthcare Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BITGF) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotage AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotage AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BITGF Stock Free BITGF Stock Alerts